Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Intra-Cellular Therapies	BELLUS Health	Y-mAbs Therapeutics	Innoviva	TG Therapeutics
Symbol	NASDAQ:ITCI	OTCMKTS:BLUSF	NASDAQ:YMAB	NASDAQ:INVA	NASDAQ:TGTX
Price Information
Current Price	$22.84	N/A	$32.97	$15.07	$15.78
52 Week Range	Buy	N/A	Buy	N/A	Buy
Analyst Ratings
Consensus Recommendation	Buy	N/A	Buy	N/A	Buy
Consensus Price Target	$35.25	N/A	$39.50	N/A	$17.67
% Upside from Price Target	54.33% upside	N/A	19.81% upside	N/A	11.96% upside
Trade Information
Market Cap	$1.27 billion	$1.40 billion	$1.31 billion	$1.53 billion	$1.57 billion
Beta	2.1	1.55	1.13	1.42	2.54
Average Volume	993,862	61,933	151,494	643,584	1,597,672
Sales & Book Value
Annual Revenue	$250,000.00	$30,000.00	N/A	$261.02 million	$150,000.00
Price / Sales	5,063.17	0.00	N/A	5.85	10,473.71
Cashflow	N/A	N/A	N/A	$4.12 per share	N/A
Price / Cash	N/A	N/A	N/A	3.66	N/A
Book Value	$5.81 per share	$0.25 per share	$4.11 per share	$3.38 per share	$0.29 per share
Price / Book	3.93	0.00	N/A	4.46	54.41
Profitability
Net Income	$-155,130,000.00	$-7,010,000.00	$-43,270,000.00	$157.29 million	$-173,480,000.00
EPS	($2.84)	N/A	($1.50)	$1.43	N/A
Trailing P/E Ratio	N/A	0.00	N/A	10.54	0.00
Forward P/E Ratio	N/A	N/A	N/A	18.60	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-49,910.34%	N/A	60.35%	-123,130.93%
Return on Equity (ROE)	-54.27%	-48.37%	-62.52%	58.66%	-2,411.79%
Return on Assets (ROA)	-45.84%	-45.25%	-55.17%	23.89%	-184.64%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.09%	N/A	0.02%	0.40%	2.77%
Current Ratio	7.77%	13.87%	7.12%	1.76%	1.00%
Quick Ratio	7.77%	13.87%	7.12%	110.18%	1.00%
Ownership Information
Institutional Ownership Percentage	70.35%	N/A	38.99%	71.72%	50.00%
Insider Ownership Percentage	18.20%	24.17%	38.40%	0.18%	14.20%
Miscellaneous
Employees	73	10	32	6	105
Shares Outstanding	55.42 million	159.12 million	39.73 million	101.28 million	99.56 million
Next Earnings Date	2/26/2020 (Estimated)	N/A	3/27/2020 (Estimated)	5/6/2020 (Estimated)	2/18/2020 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources